[go: up one dir, main page]

UA109814U - METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS - Google Patents

METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS

Info

Publication number
UA109814U
UA109814U UAU201602038U UAU201602038U UA109814U UA 109814 U UA109814 U UA 109814U UA U201602038 U UAU201602038 U UA U201602038U UA U201602038 U UAU201602038 U UA U201602038U UA 109814 U UA109814 U UA 109814U
Authority
UA
Ukraine
Prior art keywords
diabetes
disorders
patients
perimenopusal
dyghormal
Prior art date
Application number
UAU201602038U
Other languages
Ukrainian (uk)
Inventor
Катерина Олександрівна Волошинська
Тетяна Олександрівна Ілащук
Original Assignee
Вищий Державний Навчальний Заклад України "Буковинський Державний Медичний Університет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вищий Державний Навчальний Заклад України "Буковинський Державний Медичний Університет" filed Critical Вищий Державний Навчальний Заклад України "Буковинський Державний Медичний Університет"
Priority to UAU201602038U priority Critical patent/UA109814U/en
Publication of UA109814U publication Critical patent/UA109814U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Спосіб лікування хворих на артеріальну гіпертензію та цукровий діабет з перименопаузальними дисгормональними порушеннями включає базову терапію артеріальної гіпертензії та призначення препарату тівортін. При цьому препарат тівортін призначають у вигляді 14-денних курсів по 100 мл розчину (4,2 г L-аргініну) довенно, краплинно, з наступним переходом на пероральну форму по 5 мл (1 мірна ложка) 3 рази/добу протягом 14 днів.A method of treating patients with hypertension and diabetes with perimenopausal dyshormonal disorders includes basic therapy for hypertension and the administration of the drug tivortin. The drug tivortin is prescribed in the form of 14-day courses of 100 ml of solution (4.2 g of L-arginine), dropwise, followed by the conversion to the oral form of 5 ml (1 measuring spoon) 3 times / day for 14 days.

UAU201602038U 2016-03-02 2016-03-02 METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS UA109814U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201602038U UA109814U (en) 2016-03-02 2016-03-02 METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201602038U UA109814U (en) 2016-03-02 2016-03-02 METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS

Publications (1)

Publication Number Publication Date
UA109814U true UA109814U (en) 2016-09-12

Family

ID=56921218

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201602038U UA109814U (en) 2016-03-02 2016-03-02 METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS

Country Status (1)

Country Link
UA (1) UA109814U (en)

Similar Documents

Publication Publication Date Title
EA201170669A1 (en) TREATMENT OF PYRPHENIDONE PATIENTS WITH ATYPICAL LIVER FUNCTION
JOP20200156A1 (en) Esketamine for the treatment of depression
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
MX2022005812A (en) METHODS OF TREATMENT OF DISEASES AND DISORDERS RELATED TO LYSINE-SPECIFIC DEMETHYLASE 1 WITH LYSINE-SPECIFIC DEMETHYLASE 1 INHIBITORS.
EA201401028A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING EMAGOGLIFLOZIN AND MEDICINES FOR OBESITY
JOP20200031A1 (en) Methods for treating osteoarthritis with transdermal CBD gel
EA202091396A1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF METABOLIC CONDITIONS
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
CR20170121A (en) ANAMORELINE COMPOUNDS AND ITS USES
EA202091653A1 (en) MINOCYCLINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
UA109814U (en) METHOD OF TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES WITH PERIMENOPUSAL DYGHORMAL DISORDERS
RU2010153722A (en) METHOD FOR INCREASING EFFECTIVENESS OF TREATMENT OF HYPOFUNCTIONS OF OVARIES IN COWS
EA201891860A1 (en) PHARMACEUTICAL COMPOSITION OF PROLONGED SURVIVAL, CONTAINING CYSTEMINE OR ITS SALT
RU2012103957A (en) METHOD OF TREATMENT AND PREVENTION OF NASAL OBSTRUCTION IN PATIENTS WITH POLYZAL RHINOSINUSITIS
RU2011121219A (en) METHOD FOR TREATING INFLAMMATORY DISEASES OF THE PARADONT
JP1758841S (en) automatic syringe
JP1758837S (en) automatic syringe
JP1758840S (en) automatic syringe
JP1758838S (en) automatic syringe
JP1758842S (en) automatic syringe
JP1758839S (en) automatic syringe
EA201400901A1 (en) METHOD OF TREATMENT OF ALOPECIA
UA112314U (en) METHOD OF MEDICAMENTOUS CORRECTION OF PSYCHOEMOTIONAL SPHERE IN PATIENTS WITH ARTERIAL HYPERTENSION
UA83408U (en) Method for treatment of patients with chronic pancreatitis at comorbide cource of ischemic disease and syndrome of congestive heart failure
RU2011108787A (en) METHOD FOR TREATING PATIENTS WITH RED PLANE